Cris Calsada
2019
In 2019, Cris Calsada earned a total compensation of $302.9K as Chief Financial Officer at Regulus Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $45,965 |
|---|---|
| Option Awards | $151,749 |
| Salary | $104,526 |
| Other | $636 |
| Total | $302,876 |
Calsada received $151.7K in option awards, accounting for 50% of the total pay in 2019.
Calsada also received $46K in non-equity incentive plan, $104.5K in salary and $636 in other compensation.
Rankings
In 2019, Cris Calsada's compensation ranked 12,909th out of 13,971 executives tracked by ExecPay. In other words, Calsada earned more than 7.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,909 out of 13,971 | 8th |
Division Manufacturing | 5,237 out of 5,701 | 8th |
Major group Chemicals And Allied Products | 2,055 out of 2,200 | 7th |
Industry group Drugs | 1,769 out of 1,886 | 6th |
Industry Pharmaceutical Preparations | 1,307 out of 1,398 | 7th |
Source: SEC filing on April 29, 2020.
Calsada's colleagues
We found three more compensation records of executives who worked with Cris Calsada at Regulus Therapeutics in 2019.